Page last updated: 2024-10-24

apoptotic process involved in blood vessel morphogenesis

Definition

Target type: biologicalprocess

Any apoptotic process that is involved in blood vessel morphogenesis. [GOC:dph, GOC:mtg_apoptosis, GOC:TermGenie, PMID:16163358]

Apoptotic process is a tightly regulated cellular suicide program that plays a critical role in blood vessel morphogenesis, or angiogenesis. During angiogenesis, new blood vessels form from pre-existing ones through a complex series of events, including cell proliferation, migration, and differentiation. Apoptosis, or programmed cell death, is essential for shaping the developing vascular network by removing unwanted or damaged cells. Here's a detailed breakdown of how apoptosis contributes to blood vessel morphogenesis:

1. **Remodeling of the vascular network:** As new blood vessels sprout from existing ones, they often form redundant or malformed connections. Apoptosis eliminates these unnecessary cells, ensuring the formation of a functional and well-organized vascular network.

2. **Branching and sprouting:** During branching angiogenesis, new vessel sprouts emerge from existing vessels. Apoptosis is critical for creating these sprouts. Cells at the tip of the sprout undergo apoptosis, creating gaps that allow for the formation of new vessel branches.

3. **Pruning and regression:** Sometimes, newly formed blood vessels are not needed or are not properly connected to the circulatory system. Apoptosis helps to prune these redundant vessels by eliminating their cells, preventing the formation of malformed or inefficient vascular structures.

4. **Control of vascular density:** Apoptosis maintains the appropriate density of blood vessels within tissues. If there are too many vessels, they can compete for resources and compromise tissue function. Apoptosis eliminates excess vessels, ensuring optimal vascular density.

5. **Response to environmental cues:** Apoptosis in angiogenesis is responsive to various environmental cues, such as oxygen levels, growth factors, and mechanical forces. For instance, in areas with low oxygen levels (hypoxia), cells may undergo apoptosis to create space for the formation of new blood vessels that can deliver oxygen to the tissues.

6. **Regulation of vessel size and diameter:** Apoptosis also influences the size and diameter of blood vessels. Excessive cell death can lead to smaller vessels, while insufficient apoptosis can result in large, dilated vessels.

7. **Elimination of dysfunctional cells:** Apoptosis removes damaged or dysfunctional cells that may arise during angiogenesis, ensuring the formation of healthy and functional blood vessels.

In summary, apoptosis is a key regulator of blood vessel morphogenesis, playing a crucial role in shaping, pruning, and fine-tuning the vascular network. This finely-tuned process is essential for maintaining vascular integrity, delivering oxygen and nutrients to tissues, and ensuring the proper function of the circulatory system.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Bcl-2 homologous antagonist/killerA Bcl-2 homologous antagonist/killer that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q16611]Homo sapiens (human)
Apoptosis regulator BAX An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812]Homo sapiens (human)

Compounds (7)

CompoundDefinitionClassesRoles
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
alexidine dihydrchloride
6-n-tridecylsalicylic acid6-n-tridecylsalicylic acid: structure given in first sourcehydroxybenzoic acid
5,6-dehydrokawain5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source2-pyranones;
aromatic ether
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
meiogynin ameiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source
jy-1-106JY-1-106: a BH3 alpha-helix mimetic that functions as a pan-Bcl-2 inhibitor; structure in first source